CN101486674B - 格列美脲原料的制备方法 - Google Patents
格列美脲原料的制备方法 Download PDFInfo
- Publication number
- CN101486674B CN101486674B CN 200810207449 CN200810207449A CN101486674B CN 101486674 B CN101486674 B CN 101486674B CN 200810207449 CN200810207449 CN 200810207449 CN 200810207449 A CN200810207449 A CN 200810207449A CN 101486674 B CN101486674 B CN 101486674B
- Authority
- CN
- China
- Prior art keywords
- glimepiride
- compd
- wormwood
- salt
- bullion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200810207449 CN101486674B (zh) | 2008-12-19 | 2008-12-19 | 格列美脲原料的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200810207449 CN101486674B (zh) | 2008-12-19 | 2008-12-19 | 格列美脲原料的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101486674A CN101486674A (zh) | 2009-07-22 |
CN101486674B true CN101486674B (zh) | 2012-05-23 |
Family
ID=40889758
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 200810207449 Active CN101486674B (zh) | 2008-12-19 | 2008-12-19 | 格列美脲原料的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101486674B (zh) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106866485A (zh) * | 2017-02-08 | 2017-06-20 | 深圳市新阳唯康科技有限公司 | 一种格列美脲δ晶型及其制备方法 |
CN106866487A (zh) * | 2017-02-08 | 2017-06-20 | 深圳市新阳唯康科技有限公司 | 一种格列美脲ε晶型及其制备方法 |
CN106866486A (zh) * | 2017-02-08 | 2017-06-20 | 深圳市新阳唯康科技有限公司 | 一种格列美脲α晶型及其制备方法 |
CN106883161A (zh) * | 2017-02-08 | 2017-06-23 | 深圳市新阳唯康科技有限公司 | 一种格列美脲β晶型及其制备方法 |
CN110092739B (zh) * | 2019-06-04 | 2022-05-31 | 迪嘉药业集团有限公司 | 一种格列美脲中间体的制备方法 |
CN112028807A (zh) * | 2020-08-07 | 2020-12-04 | 重庆康刻尔制药股份有限公司 | 一种格列美脲原料药的精制方法 |
-
2008
- 2008-12-19 CN CN 200810207449 patent/CN101486674B/zh active Active
Non-Patent Citations (2)
Title |
---|
刘占科等.三光气法合成降糖药格列美脲.《精细化工中间体》.2006,第36卷(第3期),16-18. * |
张惠斌等.降糖药格列美脲的合成工艺研究.《中国药科大学学报》.1999,第30卷(第3期),163-165. * |
Also Published As
Publication number | Publication date |
---|---|
CN101486674A (zh) | 2009-07-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101486674B (zh) | 格列美脲原料的制备方法 | |
CN101607955B (zh) | 一种低残留硫辛酸的制备方法 | |
CN101279997B (zh) | 布***的一种制备方法 | |
EP2788323B1 (en) | New process and intermediates for the synthesis of vildagliptin | |
EP0881219A1 (en) | N-substituted dioxothiazolidylbenzamide derivatives and process for producing the same | |
JPS6154792B2 (zh) | ||
CN101671290B (zh) | 格列美脲原料药的制备方法 | |
CN105085360A (zh) | 一种高纯度维格列汀的制备方法 | |
CN104744334A (zh) | 维格列汀的制备方法 | |
CN102711764A (zh) | 神经刺激性哌嗪的合成 | |
CN104109158A (zh) | 一种纯化利伐沙班的方法 | |
CN101481363B (zh) | 一种制备瑞格列奈的方法 | |
CN103012382A (zh) | 一种奥美沙坦酯的制备方法 | |
CN101560240B (zh) | 剑麻皂素高收率的提取方法 | |
CN106687451B (zh) | 苯并硫氮杂*的合成 | |
EA012437B1 (ru) | Производные бензоконденсированных гетероциклических оксимов, способ их получения, содержащие их фармацевтическая композиция и комбинация и их применение | |
CN104447489B (zh) | 3,4-二芳基马来酰亚胺衍生物及其制备方法与应用 | |
CN102633750A (zh) | 一锅法合成治疗糖尿病的药物瑞格列奈 | |
CN1526700A (zh) | 枸橼酸莫沙必利重要中间体的合成工艺 | |
CN114349700A (zh) | 一种氧化异阿朴菲生物碱衍生物及其制备方法和抗抑郁用途 | |
CN101492413B (zh) | 卡洛芬的精制方法 | |
CN102206185B (zh) | 一种苄达赖氨酸及其类似物的精制工艺 | |
CN107737126B (zh) | 香豆素-二硫代氨基甲酸酯衍生物在制药中的应用 | |
CN114105970A (zh) | 一种利伐沙班的制备方法 | |
CN107540656A (zh) | 一种苯甲酸阿格列汀的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CP01 | Change in the name or title of a patent holder | ||
CP01 | Change in the name or title of a patent holder |
Address after: 221004, Jiangsu, Xuzhou Jinshan Development Zone, comprehensive area, the south side of the Cave Hill Co-patentee after: SHANGHAI FOSUN PHARMACEUTICAL(GROUP)CO., Ltd. Patentee after: JIANGSU WANBANG BIOPHARMACEUTICAL GROUP CO.,LTD. Address before: 221004, Jiangsu, Xuzhou Jinshan Development Zone, comprehensive area, the south side of the Cave Hill Co-patentee before: SHANGHAI FOSUN PHARMACEUTICAL(GROUP)CO., Ltd. Patentee before: Jiangsu Wan Bang Biochemical Medicine Co.,Ltd. |
|
CP03 | Change of name, title or address | ||
CP03 | Change of name, title or address |
Address after: 221004, Jiangsu, Xuzhou Jinshan Development Zone, comprehensive area, the south side of the Cave Hill Co-patentee after: SHANGHAI FOSUN PHARMACEUTICAL(GROUP)CO., Ltd. Patentee after: Jiangsu Wan Bang Biochemical Medicine Co.,Ltd. Address before: 221004 Yangshan Road, Jinshan Bridge Economic Development Zone, Xuzhou, Xuzhou, Jiangsu Co-patentee before: SHANGHAI FOSUN PHARMACEUTICAL(GROUP)CO., Ltd. Patentee before: JIANGSU WANBANG BIOPHARMACEUTICALS Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20180314 Address after: 221004, Jiangsu, Xuzhou Jinshan Development Zone, comprehensive area, the south side of the Cave Hill Co-patentee after: Xuzhou Wanbang Jinqiao Pharmaceutical Co.,Ltd. Patentee after: JIANGSU WANBANG BIOPHARMACEUTICAL GROUP CO.,LTD. Address before: 221004, Jiangsu, Xuzhou Jinshan Development Zone, comprehensive area, the south side of the Cave Hill Co-patentee before: SHANGHAI FOSUN PHARMACEUTICAL(GROUP)CO., Ltd. Patentee before: JIANGSU WANBANG BIOPHARMACEUTICAL GROUP CO.,LTD. |